| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gamida Cell Ltd. | GENERAL COUNSEL | Ordinary Shares | 855,461 | $1,325,965 | $1.55 | 31 Jan 2024 | Direct |
| Gamida Cell Ltd. | GENERAL COUNSEL | Employee Share Option (Right to Buy) | 125,860 | 08 Feb 2023 | Direct | ||
| CG Oncology, Inc. | General Counsel and Chief Compliance Officer | Employee Stock Option (Right to Buy) | 119,922 | 15 Apr 2025 | Direct | ||
| CG Oncology, Inc. | General Counsel and Chief Compliance Officer | Stock Option (Right to Buy) | 47,775 | 04 Oct 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | 15 Apr 2025 | 1 | $0 | 4 | General Counsel and Chief Compliance Officer | 16 Apr 2025, 16:15 |
| CGON | CG Oncology, Inc. | 04 Oct 2024 | 1 | $0 | 4 | General Counsel and Chief Compliance Officer | 07 Oct 2024, 16:56 |
| CGON | CG Oncology, Inc. | 15 May 2024 | 1 | $0 | 4 | General Counsel and Chief Compliance Officer | 16 May 2024, 18:57 |
| CGON | CG Oncology, Inc. | 13 May 2024 | 0 | $0 | 3 | General Counsel and Chief Compliance Officer Exhibit 24 - Power of Attorney. | 16 May 2024, 17:11 |
| /report/000141588924002308-patterson-joshua-f-2024-01-31 | Gamida Cell Ltd. | 31 Jan 2024 | 1 | $0 | 4 | GENERAL COUNSEL | 02 Feb 2024, 16:37 |
| /report/000120919123008564-patterson-joshua-f-2023-02-08 | Gamida Cell Ltd. | 08 Feb 2023 | 2 | $0 | 4 | General Counsel | 10 Feb 2023, 18:57 |
| /report/000120919122005914-patterson-joshua-f-2022-01-28 | Gamida Cell Ltd. | 28 Jan 2022 | 2 | $0 | 4 | General Counsel | 01 Feb 2022, 15:23 |
| /report/000120919122000161-patterson-joshua-f-2022-01-01 | Gamida Cell Ltd. | 01 Jan 2022 | 0 | $0 | 3 | General Counsel | 03 Jan 2022, 15:21 |